# Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy

> **NCT04469777** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alexandria University** · enrollment: 20 (actual)

## Conditions studied

- Optic Neuropathy

## Interventions

- **DRUG:** erythropoietin

## Key facts

- **NCT ID:** NCT04469777
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2020-12-15
- **Final completion:** 2020-12-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04469777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04469777, "Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04469777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*